Lamloum Demetrio, Arghittu Antonella, Ferrara Pietro, Castiglia Paolo, Dettori Marco, Gaeta Maddalena, Odone Anna, Campus Guglielmo
Department of Restorative, Pediatric and Preventive Dentistry, University of Bern, 3012 Bern, Switzerland.
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
Healthcare (Basel). 2023 Jun 30;11(13):1895. doi: 10.3390/healthcare11131895.
Untreated oral diseases are detrimental to overall well-being and quality of life and are in close relationship with social and economic consequences. The presence of strong evidence for caries primary and secondary prevention is a compulsory tool for the development of clinical practice guidelines (CPGs). This paper was aimed to assess systematically the importance of clinical practice guidelines in caries prevention management considering both the adult and pediatric populations and evaluate them using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Checklist. Records were extracted from EMBASE, SCOPUS, PubMed/Medline and seven other relevant guideline databases between 6 January and 14 February 2023. Two reviewers independently conducted the appraisal using the web-based platform My AGREE PLUS. Twenty-one guidelines/papers met the inclusion criteria and were reviewed. Eight CPGs included both primary and secondary prevention interventions, whereas thirteen presented a single preventive model. Overall, 12 guidelines were published in the USA. The mean AGREE II scores ranged from 35.4% to 84.3%. Of the total twenty-one included guidelines, twelve were classified as "Recommended", ranging from 56.3% to 84.3%, the others were described as "Recommended with modification", ranging from 35.4% to 68.9%. From the AGREE II analysis carried out, the CPGs included in this survey adopted a punctual methodological rigor but lacked applicative power. The present survey showed that the public, as the primary beneficiary, played a limited role in the development of the twenty-one CPGs. Hence, methodological improvement can better support high-quality CPG development in the future.
未经治疗的口腔疾病对整体健康和生活质量有害，并且与社会和经济后果密切相关。有强有力的证据支持龋病一级和二级预防是制定临床实践指南（CPG）的必要工具。本文旨在系统评估临床实践指南在龋病预防管理中的重要性，同时考虑成人和儿童人群，并使用《研究与评价指南评估（AGREE II）清单》对其进行评估。2023年1月6日至2月14日期间，从EMBASE、SCOPUS、PubMed/Medline和其他七个相关指南数据库中提取记录。两名评审员使用基于网络的平台My AGREE PLUS独立进行评估。二十一份指南/论文符合纳入标准并进行了评审。八项CPG包括一级和二级预防干预措施，而十三项呈现单一预防模式。总体而言，十二项指南在美国发表。AGREE II平均得分在35.4%至84.3%之间。在总共纳入的二十一份指南中，十二项被归类为“推荐”，范围从56.3%至84.3%，其他的被描述为“有修改的推荐”，范围从35.4%至68.9%。从所进行的AGREE II分析来看，本次调查纳入的CPG采用了严谨的方法，但缺乏应用能力。本次调查表明，作为主要受益者的公众在二十一份CPG的制定中发挥的作用有限。因此，方法学的改进可以更好地支持未来高质量CPG的制定。
